High-dose contrast-enhanced computed tomography (CECT) with iopamidol in the detection of cerebral metastases. Tolerance of the contrast agent.

Abstract

Intravenously administered iodinated contrast media have been demonstrated, since early experience with computed tomography of the brain, to improve clinical value of the procedure for detecting intracranial lesions. There is no universal agreement about the amount and the method of administration of the contrast medium. Many authors maintain that the use of large doses gives better results for the diagnosis of tumors and metastases. The purpose of this paper is to evaluate the tolerance of iopamidol administered by rapid intravenous infusion in a large number of patients undergoing contrast enhanced computed tomography to detect brain metastases. The authors examined 969 consecutive adult patients suffering from lung cancer, brain metastases have been detected in 17% of cases. Adverse reactions to contrast media occurred in 3 patients. Non ionic contrast media are recommended in this diagnostic procedure.

• Authors: M Leonardi, A Lavaroni, E Biasizzo, G Fabris, T Penco, F Zappoli
• Journal: Neuroradiology (Neuroradiology) Vol. 31 Issue 2 Pg. 148-50 ( 1989) ISSN: 0028-3940 [Print] Germany
• PMID: 2747892 (Publication Type: Journal Article)

Chemical References

• Iopamidol

Topics

• Adult
• Aged
• Aged, 80 and over
• Arachnoid (pathology)
• Brain Neoplasms (diagnosis, secondary)
• Cysts (diagnosis)
• Drug Tolerance
• Female
• Glioma (diagnosis)
• Humans
• Infusions, Intravenous
• Iopamidol (administration & dosage, adverse effects)
• Male
• Meningioma (diagnosis)
• Middle Aged
• Neoplasm Metastasis (diagnosis)
• Tomography, X-Ray Computed (methods)